Business Process Outsourcing
PRODUCTS
-
From regulatory pathway selection to patient recruitment challenges to navigating the volume of data to collect and clean — a rare disease therapy requires an extraordinary amount of coordination.
-
There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough understanding of sections 505(b)(1) and 505(b)(2) of the Federal Food, Drug, and Cosmetics (FD&C) Act.
-
Leverage our team of expert cell media scientists to develop, refine, and deliver a complete formula tailor-made to your specifications. A concierge approach to custom media design.
-
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
A scalable, high-throughput, high-content screening solution with 7-channel high-intensity laser light source and machine learning capabilities.
WHITE PAPERS AND CASE STUDIES
-
Drug-Drug Interaction Study On A Novel Cardiovascular Medication
Learn how Altasciences leveraged its expertise to design, recruit, and conduct complex DDI studies, assessing pharmacokinetic and pharmacodynamic impacts of co-administered drugs.
-
Reducing Product Degradation With Pneumatic Conveying Systems
A leading multinational chain of coffee houses and roastery reserves encountered challenges when conveying their beans to a new roaster. Gain insight into the solution to their complex conveying needs.
-
eTMF As A Factory: Elements For High-Volume, High-Quality Processing
In an ideal scenario, the eTMF would operate like a well-oiled factory. Examine some of the key factors that would support making “The eTMF Factory” a reality.
-
Five Essentials For Accurate Oligonucleotide Chemistry
Explore five key areas in oligonucleotide chemistry where improvements will have a huge influence on your synthesis quality.
-
Consider India For Your Next HCC International Trial
Assess the feasibility of India as a potential venue for HCC trials as well as its epidemiology, historical perceptions, and untapped potential for international clinical research opportunities.
-
University Of Ottawa Relies On The BEAMAGE Series To Measure Laser Profiles
The University of Ottawa lab successfully used beam profilers to improve Power-Over-Fiber receiver chip development, ensuring precise, efficient laser measurements for advanced photonic research.
-
Could RFID-Based Unit-Level Traceability Be Key To Operational Excellence?
Radiofrequency identification (RFID)-based unit-level tracking solutions for prefilled syringes are poised to help pharma manufacturers address key risks and costly bottlenecks related to the fill-finish process.
-
Earning RMAT Designation - What Developers Need To Know
Explore a high-level overview of the Regenerative Medicine Advanced Therapy designation and how to ensure success and accelerate advanced therapy products toward commercialization.
-
Site Satisfaction: Influencing Tech Development Strategies
Technology is playing an increasingly important role in clinical trials, helping to improve efficiency, compliance, and data quality. Learn why it’s critical that clinical study technologies are easy to use across sites and fit into the team’s workflows.
-
Focus On Your Core Business Strategy
Learn how a large manufacturing client helped to focus on their core business with a solution that transitioned approximately 60% of the workforce and capitalized on the initial training investment.
-
From Paper To Digital Study Management In Large Patient Registries
Uncover how this sponsor was able to independently design and oversee its clinical study, minimizing external assistance, and easing the workload for their sites through mobile app accessibility.
-
How To Recruit 236 Patients In An Osteoarthritis Study On Time During The Peak Of The Pandemic
A leading Eastern European contract research organization completed the recruitment of 236 subjects in a Phase 3 osteoarthritis study for Handok Inc. despite hurdles caused by the COVID-19 pandemic.
NEWS
-
New Progress Semaphore Release Unleashes AI To Drive Smarter Enterprise Knowledge Management6/25/2025
Progress Software (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced the latest release of Progress® Semaphore™, its metadata management and semantic AI platform.
-
Mitsubishi UFJ Capital And AGC Sign A Mandate Agreement For The Technical Evaluation Of Drug Manufacturing For Investment Activities In Drug Discovery Start-ups3/4/2025
Mitsubishi UFJ Capital Co., Ltd.(Mitsubishi UFJ Capital; President: Takuro Kojima, Headquarters: Tokyo)and AGC Inc. (AGC; President: Yoshinori Hirai, Headquarters: Tokyo)have signed a mandate agreement for the technical evaluation of drug manufacturing, as part of Mitsubishi UFJ Capital's investment activities in drug discovery startups, etc.
-
Predictive Oncology Partners With Switzerland-Based Tecan Group Ltd. To Expand High-Throughput Drug Screening To Include Human Tumor Spheroids Using Automated Imaging And 3D Analysis2/10/2025
Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that positive results from an ongoing study in collaboration with Switzerland-based Tecan, Ltd. were recently presented at the 2025 Society for Laboratory Automation and Screening (SLAS) International Conference & Exhibition, which was held January 25-29, 2025, in San Diego, CA.
-
DentTracks Unveils AI-Powered All-In-One Tech Ecosystem For Dental Practices6/5/2025
DentTracks today announced the official launch of its proprietary AI-powered, cloud-based ecosystem designed to streamline dental practice operations and boost profitability.
-
MIT Researchers Remotely Map Crops, Field By Field2/15/2024
Crop maps help scientists and policymakers track global food supplies and estimate how they might shift with climate change and growing populations.